Morgan Stanley’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74 Hold
20
﹤0.01% 7863
2025
Q4
$48 Sell
20
-60
-75% -$265 ﹤0.01% 7870
2025
Q3
$456 Sell
80
-4
-5% -$31 ﹤0.01% 7510
2025
Q2
$359 Sell
84
-6
-7% -$69 ﹤0.01% 7498
2025
Q1
$1.49K Buy
90
+30
+50% +$564 ﹤0.01% 7228
2024
Q4
$1.16K Sell
60
-40
-40% -$1.14K ﹤0.01% 7251
2024
Q3
$4.26K Sell
100
-1,090
-92% -$73K ﹤0.01% 6958
2024
Q2
$90.3K Sell
1,190
-4,450
-79% -$477K ﹤0.01% 5996
2024
Q1
$1.04M Buy
5,640
+5,240
+1,310% +$1.03M ﹤0.01% 4935
2023
Q4
$44.3K Buy
+400
New +$59.2K ﹤0.01% 6422
2023
Q1
Hold
0
-$12 7767
2022
Q4
Hold
0
7795

Other funds holding ICU

Morgan Stanley's ICU Position: Q1 2026 in Review

Morgan Stanley held its SeaStar Medical (ICU) position steady in Q1 2026 at 20 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #7863.

Morgan Stanley first reported a position in ICU in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.04M in Q1 2024. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

  • Morgan Stanley held 20 shares of SeaStar Medical worth $74 as of Q1 2026.
  • Morgan Stanley left its SeaStar Medical share count unchanged in Q1 2026.
  • SeaStar Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7863 holding.
  • Morgan Stanley first reported a position in SeaStar Medical in Q4 2023 and has held it in 10 quarters since.
  • Morgan Stanley's SeaStar Medical position peaked at $1.04M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.